-
Global Biopharma Layoffs April 2026
Layoffs
Global Biopharma companies including Novo Nordisk, IO Biotech, and BioNTech announce workforce reductions in April 2026 as part of cost-saving and strategic realignments, impacting research, technology, and leadership roles across their operations.
-
Global Biopharma Layoffs June 2025
Layoffs
Biopharma layoffs surge in June 2025 as major companies like Genentech, Vertex, and Recursion downsize. Explore the latest job cuts, site closures, and restructuring trends across the industry.
-
BioNTech Acquires CureVac in $1.25B mRNA Deal
BioNTech
BioNTech acquires CureVac in a $1.25 billion all-stock deal, expanding its mRNA cancer therapy pipeline and resolving ongoing litigation. The acquisition strengthens BioNTech’s oncology strategy and manufacturing capabilities.
-
-
-
-
Big Pharma -Waiting for the other Shoe to Drop
Biotech
Explore the shifting landscape of big pharma as clinical trial results, patent cliffs, and innovative therapies shape 2025. Discover how giants like Eli Lilly, Pfizer, and Novo Nordisk navigate challenges and opportunities in weight loss, oncology, and vaccines.
射洪县|
曲阳县|
武定县|
德钦县|
涪陵区|
通化市|
潞西市|
安泽县|
丰都县|
赤城县|
潢川县|
韩城市|
南阳市|
额敏县|
广昌县|
同心县|
亳州市|
文昌市|
武强县|
沁阳市|
广汉市|
都安|
双鸭山市|
科尔|
泰兴市|
徐闻县|
绥德县|
辽宁省|
鄢陵县|
隆安县|
巴中市|
罗平县|
和政县|
阿瓦提县|
多伦县|
彰武县|
当阳市|
宁远县|
梧州市|
邵东县|
镇安县|